UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

The Journal of heart and lung transplantation, 2012-09, Vol.31 (9), p.913-933

2012

Volltextzugriff (PDF)

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance

The Journal of heart and lung transplantation, 2015-03, Vol.34 (3), p.362-368

2015

Volltextzugriff (PDF)

Ethical considerations of thoracic transplant and circulatory support during the COVID-19 pandemic: A closer look at pulmonary vascular disease

The Journal of heart and lung transplantation, 2020-08, Vol.39 (8), p.852-853

2020

Volltextzugriff (PDF)

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review

The Journal of heart and lung transplantation, 2021-03, Vol.40 (3), p.172-182

2021

Volltextzugriff (PDF)

Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.300-309

2020

Volltextzugriff (PDF)

National trends and inpatient outcomes of pulmonary arterial hypertension related hospitalizations – Analysis of the National Inpatient Sample Database

International journal of cardiology, 2020-11, Vol.319, p.131-138

2020

Volltextzugriff (PDF)

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis

The Journal of heart and lung transplantation, 2015-03, Vol.34 (3), p.356-361

2015

Volltextzugriff (PDF)

Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

The Journal of heart and lung transplantation, 2021-10, Vol.40 (10), p.1172-1180

2021

Volltextzugriff (PDF)

Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension

The Journal of heart and lung transplantation, 2018-03, Vol.37 (3), p.365-375

2018

Volltextzugriff (PDF)

Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study

The Journal of heart and lung transplantation, 2022-03, Vol.41 (3), p.411-420

2022

Volltextzugriff (PDF)

Risk scores as a surrogate in pulmonary arterial hypertension: a different lens

The lancet respiratory medicine, 2024-03, Vol.12 (3), p.e9-e10

2024

Volltextzugriff (PDF)

Phenotypes of idiopathic pulmonary arterial hypertension

The lancet respiratory medicine, 2022-10, Vol.10 (10), p.e89-e89

2022

Volltextzugriff (PDF)

Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV

The Journal of heart and lung transplantation, 2022-11, Vol.41 (11), p.1572-1580

2022

Volltextzugriff (PDF)

Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE

International journal of cardiology, 2020-10, Vol.317, p.188-192

2020

Volltextzugriff (PDF)

Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis

The Journal of heart and lung transplantation, 2023-02, Vol.42 (2), p.275-282

2023

Volltextzugriff (PDF)

REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat

The Journal of heart and lung transplantation, 2018-07, Vol.37 (7), p.836-843

2018

Volltextzugriff (PDF)

Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study

The Journal of heart and lung transplantation, 2024-06

2024

Volltextzugriff (PDF)

Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study

The Journal of heart and lung transplantation, 2019-01, Vol.38 (1), p.43-50

2019

Volltextzugriff (PDF)

Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis

The Journal of heart and lung transplantation, 2018-06, Vol.37 (6), p.696-705

2018

Volltextzugriff (PDF)

Pulmonary hypertension related to left heart disease: Insight from a wireless implantable hemodynamic monitor

The Journal of heart and lung transplantation, 2015-03, Vol.34 (3), p.329-337

2015

Volltextzugriff (PDF)

Impact of thoracotomy approach on right ventricular failure and length of stay in left ventricular assist device implants: an intermacs registry analysis

The Journal of heart and lung transplantation, 2021-09, Vol.40 (9), p.981-989

2021

Volltextzugriff (PDF)

A Case Report of a Patient With Pulmonary Arterial Hypertension Transitioned From Inhaled Iloprost to Selexipag

Journal of pharmacy practice, 2021-12, Vol.34 (6), p.980-983

2021

Volltextzugriff (PDF)

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials

The Journal of heart and lung transplantation, 2011-09, Vol.30 (9), p.982-989

2011

Volltextzugriff (PDF)

Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension

International journal of cardiology, 2019-09, Vol.291, p.134-139

2019

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

KollektionElektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(115)

Publikationsform

Sprache

Englisch
(131)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(96)
Science & Technology
(96)
Humans
(86)
Cardiovascular System & Cardiology
(68)
Cardiac & Cardiovascular Systems
(64)
Respiratory System
(55)
Surgery
(55)
Transplantation
(55)
Male
(43)
Female
(42)
Middle Aged
(38)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Adult
(30)
Pulmonary Arterial Hypertension
(28)
Aged
(22)
Hypertension, Pulmonary - Physiopathology
(18)
Pulmonary Hypertension
(18)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(18)
Surgery Of The Heart
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance

Ethical considerations of thoracic transplant and circulatory support during the COVID-19 pandemic: A closer look at pulmonary vascular disease

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review

Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study

National trends and inpatient outcomes of pulmonary arterial hypertension related hospitalizations – Analysis of the National Inpatient Sample Database

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis

Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension

Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study

Risk scores as a surrogate in pulmonary arterial hypertension: a different lens

Phenotypes of idiopathic pulmonary arterial hypertension

Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV

Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE

Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis

REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat

Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study

Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study

Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis

Pulmonary hypertension related to left heart disease: Insight from a wireless implantable hemodynamic monitor

Impact of thoracotomy approach on right ventricular failure and length of stay in left ventricular assist device implants: an intermacs registry analysis

A Case Report of a Patient With Pulmonary Arterial Hypertension Transitioned From Inhaled Iloprost to Selexipag

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials

Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension

Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension

Aktive Filter

Suchergebnisse filtern